Truvestments Capital’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51K Hold
54
– – ﹤0.01% 1029
2026
Q1
$1.54K Hold
54
– – ﹤0.01% 1022
2025
Q4
$2.14K Hold
54
– – ﹤0.01% 880
2025
Q3
$1.9K Hold
54
– – ﹤0.01% 923
2025
Q2
$1.77K Hold
54
– – ﹤0.01% 853
2025
Q1
$1.74K Hold
54
– – ﹤0.01% 882
2024
Q4
$1.65K Hold
54
– – ﹤0.01% 872
2024
Q3
$1.51K Buy
+54
New +$1.33K ﹤0.01% 825
2024
Q2
– Sell
-54
Closed -$1.64K – 258
2024
Q1
$1.64K Hold
54
– – ﹤0.01% 630
2023
Q4
$1.93K Hold
54
– – ﹤0.01% 679
2023
Q3
$2.37K Hold
54
– – ﹤0.01% 578
2023
Q2
$2.67K Hold
54
– – ﹤0.01% 583
2023
Q1
$2.24K Sell
54
-37
-41% -$1.53K ﹤0.01% 575
2022
Q4
$4.04K Sell
91
-35
-28% -$1.46K ﹤0.01% 578
2022
Q3
$5K Hold
126
– – ﹤0.01% 465
2022
Q2
$5K Buy
+126
New +$5.97K ﹤0.01% 473
2022
Q1
– Sell
-89
Closed -$6K – 210
2021
Q4
$6K Hold
89
– – ﹤0.01% 450
2021
Q3
$6K Hold
89
– – ﹤0.01% 428
2021
Q2
$7K Hold
89
– – ﹤0.01% 421
2021
Q1
$6K Sell
89
-31
-26% -$1.91K ﹤0.01% 498
2020
Q4
$6K Buy
+120
New +$5.19K ﹤0.01% 470
2020
Q3
– Sell
-120
Closed -$5K – 340
2020
Q2
$5K Buy
+120
New +$5.22K 0.01% 461
2019
Q4
– Sell
-212
Closed -$5K – 171
2019
Q3
$5K Sell
212
-21
-9% -$600 ﹤0.01% 565
2019
Q2
$7K Hold
233
– – ﹤0.01% 569
2019
Q1
$6K Buy
+233
New +$7.08K ﹤0.01% 573
2018
Q3
$9K Buy
+247
New +$7.82K ﹤0.01% 651

Other funds holding ATRC

Truvestments Capital's ATRC Position: Q2 2026 in Review

Truvestments Capital held its AtriCure (ATRC) position steady in Q2 2026 at 54 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1029.

Truvestments Capital first reported a position in ATRC in Q3 2018 and has held it in 26 quarters since. The position peaked at $9K in Q3 2018. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Truvestments Capital held 54 shares of AtriCure worth $1.51K as of Q2 2026.
  • Truvestments Capital left its AtriCure share count unchanged in Q2 2026.
  • AtriCure made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #1029 holding.
  • Truvestments Capital first reported a position in AtriCure in Q3 2018 and has held it in 26 quarters since.
  • Truvestments Capital's AtriCure position peaked at $9K in Q3 2018.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.